Found: 29
Select item for more details and to access through your institution.
Dendritic Cells in Cancer Immunology and Immunotherapy.
- Published in:
- Cancers, 2024, v. 16, n. 5, p. 981, doi. 10.3390/cancers16050981
- By:
- Publication type:
- Article
Mutated trimeric RBD vaccines: a platform against variants of concern.
- Published in:
- Signal Transduction & Targeted Therapy, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41392-023-01426-3
- By:
- Publication type:
- Article
Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.985886
- By:
- Publication type:
- Article
Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.991311
- By:
- Publication type:
- Article
Therapeutic Vaccines against Hepatocellular Carcinoma in the Immune Checkpoint Inhibitor Era: Time for Neoantigens?
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 4, p. 2022, doi. 10.3390/ijms23042022
- By:
- Publication type:
- Article
The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3248, doi. 10.3390/cancers13133248
- By:
- Publication type:
- Article
The mutational load and a T-cell inflamed tumour phenotype identify ovarian cancer patients rendering tumour-reactive T cells from PD-1<sup>+</sup> tumour-infiltrating lymphocytes.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Cold-Inducible RNA Binding Protein as a Vaccination Platform to Enhance Immunotherapeutic Responses against Hepatocellular Carcinoma.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3397, doi. 10.3390/cancers12113397
- By:
- Publication type:
- Article
Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model.
- Published in:
- Cancer Immunology, Immunotherapy, 2019, v. 68, n. 3, p. 379, doi. 10.1007/s00262-018-2283-0
- By:
- Publication type:
- Article
Enhancement of Antitumor Vaccination by Targeting Dendritic Cell-Related IL-10.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.01923
- By:
- Publication type:
- Article
Immunomodulatory Properties of Carvone Inhalation and Its Effects on Contextual Fear Memory in Mice.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00068
- By:
- Publication type:
- Article
Gene expression analysis during acute hepatitis C virus infection associates dendritic cell activation with viral clearance.
- Published in:
- Journal of Medical Virology, 2016, v. 88, n. 5, p. 843, doi. 10.1002/jmv.24399
- By:
- Publication type:
- Article
Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation.
- Published in:
- Liver International, 2015, v. 35, n. 5, p. 1590, doi. 10.1111/liv.12592
- By:
- Publication type:
- Article
A Fusion Protein between Streptavidin and the Endogenous TLR4 Ligand EDA Targets Biotinylated Antigens to Dendritic Cells and Induces T Cell Responses In Vivo.
- Published in:
- BioMed Research International, 2013, v. 2013, p. 1, doi. 10.1155/2013/864720
- By:
- Publication type:
- Article
Eradication of large tumors expressing human papillomavirus E7 protein by therapeutic vaccination with E7 fused to the extra domain a from fibronectin.
- Published in:
- International Journal of Cancer, 2012, v. 131, n. 3, p. 641, doi. 10.1002/ijc.26412
- By:
- Publication type:
- Article
Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 10, p. 1383, doi. 10.1007/s00262-011-1036-0
- By:
- Publication type:
- Article
International symposium on CTL and immunostimulation, Pamplona (Spain), October 26th and 27th 2010.
- Published in:
- 2011
- By:
- Publication type:
- Report
Peptide inhibitors of transforming growth factor-β enhance the efficacy of antitumor immunotherapy.
- Published in:
- International Journal of Cancer, 2009, v. 125, n. 11, p. 2614, doi. 10.1002/ijc.24656
- By:
- Publication type:
- Article
A synthetic peptide from transforming growth factor-{beta}1 type III receptor prevents myocardial fibrosis in spontaneously hypertensive rats.
- Published in:
- Cardiovascular Research, 2009, v. 81, n. 3, p. 601
- By:
- Publication type:
- Article
Combined immunization with adjuvant molecules poly(I:C) and anti-CD40 plus a tumor antigen has potent prophylactic and therapeutic antitumor effects.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 1, p. 19, doi. 10.1007/s00262-007-0346-8
- By:
- Publication type:
- Article
Vaccination Against Hepatitis C Virus With Dendritic Cells Transduced With an Adenovirus Encoding NS3 Protein.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 1, p. 210, doi. 10.1038/sj.mt.6300333
- By:
- Publication type:
- Article
The combined actions of NK and T lymphocytes are necessary to reject an EGFP+ mesenchymal tumor through mechanisms dependent on NKG2D and IFNγ.
- Published in:
- International Journal of Cancer, 2007, v. 121, n. 6, p. 1282, doi. 10.1002/ijc.22795
- By:
- Publication type:
- Article
The DSS LOGDIS Optimizes Delivery Routes for FRILAC's Frozen Products.
- Published in:
- Interfaces, 2005, v. 35, n. 3, p. 202, doi. 10.1287/inte.1050.0134
- By:
- Publication type:
- Article
Identification of HLA-B27-restricted cytotoxic T lymphocyte epitope from carcinoembryonic antigen.
- Published in:
- International Journal of Cancer, 2002, v. 97, n. 1, p. 58, doi. 10.1002/ijc.1579
- By:
- Publication type:
- Article
Immunization with a tumor-associated CTL epitope plus a tumor-related or unrelated Th1 helper peptide elicits protective CTL immunity.
- Published in:
- European Journal of Immunology, 2001, v. 31, n. 6, p. 1780, doi. 10.1002/1521-4141(200106)31:6<1780::AID-IMMU1780>3.0.CO;2-I
- By:
- Publication type:
- Article
Th1 but not Th0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides.
- Published in:
- International Immunology, 1999, v. 11, n. 12, p. 2025, doi. 10.1093/intimm/11.12.2025
- By:
- Publication type:
- Article
Simple strategy to induce antibodies of distinct specificity: Application to the mapping of gp120 and inhibition of HIV-1 infectivity.
- Published in:
- European Journal of Immunology, 1995, v. 25, n. 4, p. 877, doi. 10.1002/eji.1830250403
- By:
- Publication type:
- Article
Induction of antibodies against a peptide hapten does not require covalent linkage between the hapten and a class II presentable T helper peptide.
- Published in:
- European Journal of Immunology, 1991, v. 21, n. 6, p. 1555, doi. 10.1002/eji.1830210633
- By:
- Publication type:
- Article
Polarity of immunogens: implications for vaccine design.
- Published in:
- European Journal of Immunology, 1990, v. 20, n. 10, p. 2363, doi. 10.1002/eji.1830201031
- By:
- Publication type:
- Article